2021 GLOBAL FINALIST
Proteona
Digital Health
Proteona is a precision medicine company that is pioneering the use of single-cell multi-omics to improve cancer clinical outcomes. Using a combination of innovative single-cell assays and AI-assisted bioinformatics, Proteona enables pharma companies, biotech partners and clinicians to integrate single-cell level precision into clinical projects.
💸 Select investors: Pix Vine Capital
📌 HQ: Singapore
In the news
Proteona Awards $100,000 in grant funding to multiple myeloma clinical projects aiming to improve treatment outcomes
🗓️ 20 Apr 2021 | Press Release
🗓️ 20 Apr 2021 | Press Release